Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Preventing Long-Term Neurologic Disability in Hemophilia (A): Cost-Effectiveness of Emicizumab Prophylaxis for the Prevention of Intracranial Hemorrhage in Infants with Severe Hemophilia (A)

Samira Glaeser-Khan, Rhys Richmond, Satoko Ito, Robert D Bona, Harlan M. Krumholz, Adam Cuker, George Goshua

Blood (2024) 144 (Supplement 1): 157.

https://doi.org/10.1182/blood-2024-203690

Published: 2024

Journal Articles

Characterizing an Underdiagnosed Condition: Hemophilia in Females

Valentina Restrepo, Stephanie Prozora, Evangelia Louizos, Layla N Van Doren, Robert D Bona

Blood (2024) 144 (Supplement 1): 2584.

https://doi.org/10.1182/blood-2024-210735

Published: 2024

Journal Articles

Correlation of Low Variant Allele Frequency STAT3 Gain-of-Function Mutations and T-Cell Clonality with Cyclic Thrombocytopenia

Haiyu Zhang, Henning Stehr, Robert D Bona, Jean M. Connors, William Shomali, Jason Gotlib, James B. Bussel, James L. Zehnder

Blood (2024) 144 (Supplement 1): 1175.

https://doi.org/10.1182/blood-2024-211695

Published: 2024

Journal Articles

Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States

Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D. Bona, Adam Cuker, George Goshua

Blood (2024) 143 (22): 2332–2335.

https://doi.org/10.1182/blood.2024024209

Published: 2024

Includes: Supplemental data

Journal Articles

Multimodality Platelet Evaluation By Mass Cytometry and Genetic Analysis in Patients with Bleeding Disorders

Sean X Gu, Patrick G Gallagher, Ayesha Butt, Vivian W Gu, Kimberly Lezon-Geyda, Vincent P Schulz, Stephanie Prozora, Alfred I Lee, Natalia Neparidze, Noffar Bar, Kelsey Martin, Jennifer Cornell, Giavanna Chirico, Raja Chakraborty, Henry M Rinder, John Hwa, Robert D Bona

Blood (2023) 142 (Supplement 1): 1197.

https://doi.org/10.1182/blood-2023-177946

Published: 2023

Journal Articles

Characterizing Outpatient Classical Hematology Referrals at an Academic Healthcare System

Eric Y Chang, Anna Kress, Friedrich Ackermann, Monica Fradkin, Stephanie Halene, Elizabeth Herbert, Lisa Shomsky, Latha Sudhakar, Alfred I Lee, Robert D Bona

Blood (2023) 142 (Supplement 1): 7196.

https://doi.org/10.1182/blood-2023-186065

Published: 2023

Journal Articles

Cost-Effectiveness of Long-Term Prophylaxis with Plasma-Derived Vs. Recombinant Von Willebrand Factor in Severe Von Willebrand Disease

Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D Bona, Adam Cuker, George Goshua

Blood (2023) 142 (Supplement 1): 3698.

https://doi.org/10.1182/blood-2023-188018

Published: 2023

Journal Articles

Equitable Care for Severe Hemophilia_A: Distributional Cost-Effectiveness of Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in Patients with Severe Hemophilia_A in the United States

Satoko Ito, Kunal C Potnis, Cecily Allen, Rhys Richmond, Christina Waldron, Giri Viswanathan, Robert D Bona, George Goshua

Blood (2023) 142 (Supplement 1): 492.

https://doi.org/10.1182/blood-2023-190420

Published: 2023

Journal Articles

Iron Infusion Reactions: Risk Factors and Real-World Experience

Ayesha Butt, Tinatin Muradashvili, Sara Soliman, George Goshua, Adrienne Joy Burns, Noffar Bar, Kelsey Martin, Gena Borgman, Robert D. Bona, Alfred Ian Lee, Natalia Neparidze

Blood (2021) 138 (Supplement 1): 4154.

https://doi.org/10.1182/blood-2021-151048

Published: 2021

Journal Articles

Venous Thromboembolism (VTE) Education Preferences Amongst Physicians and Patients: A Qualitative Needs Assessment

Prerak V Juthani, BA, Danya Muneer Ahmed, Osama Muneer Ahmed, BA, BS, Robert D. Bona, MD, Natalia Neparidze, MD, Alfred Ian Lee, MD PhD

Blood (2018) 132 (Supplement 1): 5810.

https://doi.org/10.1182/blood-2018-99-119418

Published: 2018

NARROW

Preventing Long-Term Neurologic Disability in Hemophilia (A): Cost-Effectiveness of Emicizumab Prophylaxis for the Prevention of Intracranial Hemorrhage in Infants with Severe Hemophilia (A)

Characterizing an Underdiagnosed Condition: Hemophilia in Females

Correlation of Low Variant Allele Frequency STAT3 Gain-of-Function Mutations and T-Cell Clonality with Cyclic Thrombocytopenia

Cost-effectiveness of prophylaxis with recombinant vs plasma-derived VWF in severe von Willebrand disease in the United States

Multimodality Platelet Evaluation By Mass Cytometry and Genetic Analysis in Patients with Bleeding Disorders

Characterizing Outpatient Classical Hematology Referrals at an Academic Healthcare System

Cost-Effectiveness of Long-Term Prophylaxis with Plasma-Derived Vs. Recombinant Von Willebrand Factor in Severe Von Willebrand Disease

Equitable Care for Severe Hemophilia_A: Distributional Cost-Effectiveness of Prophylactic Weekly Efanesoctocog Alfa Versus Standard-Care Factor VIII in Patients with Severe Hemophilia_A in the United States

Iron Infusion Reactions: Risk Factors and Real-World Experience

Venous Thromboembolism (VTE) Education Preferences Amongst Physicians and Patients: A Qualitative Needs Assessment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only